User menu

Implementation of the European multicentre database of healthy controls for [(123)I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes.

Bibliographic reference Albert, Nathalie L ; Unterrainer, Marcus ; Diemling, Markus ; Xiong, Guoming ; Bartenstein, Peter ; et. al. Implementation of the European multicentre database of healthy controls for [(123)I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes.. In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 43, no.7, p. 1315-1322 (2016)
Permanent URL
  1. Suwijn Sven R, van Boheemen Caroline JM, de Haan Rob J, Tissingh Gerrit, Booij Jan, de Bie Rob MA, The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson’s disease or clinically uncertain parkinsonism: a systematic review, 10.1186/s13550-015-0087-1
  2. Benamer Hani T. S., Patterson Jim, Grosset Donald G., Booij J., de Bruin K., van Royen E., Speelman J. D., Horstink M. H. I. M., Sips H. J. W. A., Dierckx R. A., Versijpt J., Decoo D., Van Der Linden C., Hadley D. M., Doder M., Lees A. J., Costa D. C., Gacinovic S., Oertel W. H., Pogarell O., Hoeffken H., Joseph K., Tatsch K., Schwarz J., Ries V., Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: The [123I]-FP-CIT study group, 10.1002/1531-8257(200005)15:3<503::aid-mds1013>;2-v
  3. Darcourt Jacques, Booij Jan, Tatsch Klaus, Varrone Andrea, Vander Borght Thierry, Kapucu Özlem L., Någren Kjell, Nobili Flavio, Walker Zuzana, Van Laere Koen, EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2, 10.1007/s00259-009-1267-x
  4. McKeith Ian, O'Brien John, Walker Zuzana, Tatsch Klaus, Booij Jan, Darcourt Jacques, Padovani Alessandro, Giubbini Raffaele, Bonuccelli Ubaldo, Volterrani Duccio, Holmes Clive, Kemp Paul, Tabet Naji, Meyer Ines, Reininger Cornelia, Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study, 10.1016/s1474-4422(07)70057-1
  5. Booij Jan, Speelman Johannes D., Horstink Martin W. I. M., Wolters Erik C., The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism, 10.1007/s002590000460
  6. Scherfler Christoph, Schwarz Johannes, Antonini Angelo, Grosset Donald, Valldeoriola Francesc, Marek Kenneth, Oertel Wolfgang, Tolosa Eduardo, Lees Andrew J., Poewe Werner, Role of DAT-SPECT in the diagnostic work up of Parkinsonism, 10.1002/mds.21505
  7. Hughes Andrew J., Daniel Susan E., Ben‐Shlomo Yoav, Lees Andrew J., The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service, 10.1093/brain/awf080
  8. Plotkin M., Amthauer H., Klaffke S., K�hn A., L�demann L., Arnold G., Wernecke K.-D., Kupsch A., Felix R., Venz S., Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients, 10.1007/s00702-004-0208-x
  9. Catafau Ana M., Tolosa Eduardo, , Impact of dopamine transporter SPECT using123I-Ioflupane on diagnosis and management of patients with clinically uncertain parkinsonian syndromes, 10.1002/mds.20112
  10. Tolosa Eduardo, Borght Thierry Vander, Moreno Emilio, Accuracy of DaTSCAN (123I-ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-Year follow-up of an open-label study, 10.1002/mds.21710
  11. Varrone Andrea, Dickson John C., Tossici-Bolt Livia, Sera Terez, Asenbaum Susanne, Booij Jan, Kapucu Ozlem L., Kluge Andreas, Knudsen Gitte M., Koulibaly Pierre Malick, Nobili Flavio, Pagani Marco, Sabri Osama, Vander Borght Thierry, Van Laere Koen, Tatsch Klaus, European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis, 10.1007/s00259-012-2276-8
  12. Koch W, Pogarell O, Pöpperl G, Hornung J, Hamann C, Gildehaus F-J, et al. Extended studies of the striatal uptake of 99mTc-NC100697 in healthy volunteers. J Nucl Med. 2007;48:27–34.
  13. Tossici-Bolt Livia, Dickson John C., Sera Terez, de Nijs Robin, Bagnara Maria Claudia, Jonsson Catherine, Scheepers Egon, Zito Felicia, Seese Anita, Koulibaly Pierre Malick, Kapucu Ozlem L., Koole Michel, Raith Maria, George Jean, Lonsdale Markus Nowak, Münzing Wolfgang, Tatsch Klaus, Varrone Andrea, Calibration of gamma camera systems for a multicentre European 123I-FP-CIT SPECT normal database, 10.1007/s00259-011-1801-5
  14. BECK A. T., An Inventory for Measuring Depression, 10.1001/archpsyc.1961.01710120031004
  15. Derogatis L. R., Rickels K., Rock A. F., The SCL-90 and the MMPI: a step in the validation of a new self-report scale, 10.1192/bjp.128.3.280
  16. Kangasmaa Tuija, Sohlberg Antti, Kuikka Jyrki T., Reduction of Collimator Correction Artefacts with Bayesian Reconstruction in Spect, 10.1155/2011/630813
  17. Koch Walter, Unterrainer Marcus, Xiong Guoming, Bartenstein Peter, Diemling Markus, Varrone Andrea, Dickson John C., Tossici-Bolt Livia, Sera Terez, Asenbaum Susanne, Booij Jan, Kapucu Ozlem L., Kluge Andreas, Ziebell Morten, Darcourt Jacques, Nobili Flavio, Pagani Marco, Hesse Swen, Vander Borght Thierry, Van Laere Koen, Tatsch Klaus, la Fougère Christian, Extrastriatal binding of [123I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls, 10.1007/s00259-014-2785-8
  18. Collins D. Louis, Neelin Peter, Peters Terrence M., Evans Alan C., Automatic 3D Intersubject Registration of MR Volumetric Data in Standardized Talairach Space : , 10.1097/00004728-199403000-00005
  19. Koch W, Radau PE, Hamann C, Tatsch K. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. J Nucl Med. 2005;46:1109–18.
  20. Tzourio-Mazoyer N., Landeau B., Papathanassiou D., Crivello F., Etard O., Delcroix N., Mazoyer B., Joliot M., Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain, 10.1006/nimg.2001.0978
  21. Mozley PD, Acton PD, Barraclough ED, Plössl K, Gur RC, Alavi A, et al. Effects of age on dopamine transporters in healthy humans. J Nucl Med. 1999;40:1812–7.
  22. Schwarz J, Storch A, Koch W, Pogarell O, Radau PE, Tatsch K. Loss of dopamine transporter binding in Parkinson’s disease follows a single exponential rather than linear decline. J Nucl Med. 2004;45:1694–7.
  23. la Fougere C., Popperl G., Levin J., Wangler B., Boning G., Uebleis C., Cumming P., Bartenstein P., Botzel K., Tatsch K., The Value of the Dopamine D2/3 Receptor Ligand 18F-Desmethoxyfallypride for the Differentiation of Idiopathic and Nonidiopathic Parkinsonian Syndromes, 10.2967/jnumed.109.071811
  24. CHOUKER M., TATSCH K., LINKE R., POGARELL O., HAHN K., SCHWARZ J., Striatal dopamine transporter binding in early to moderately advanced Parkinsonʼs disease: monitoring of disease progression over 2 years : , 10.1097/00006231-200106000-00017
  25. Marek K, Seibyl J. Beta-CIT scans without evidence of dopaminergic deficit (SWEDD) in the ELLDOPA-CIT and CALM-cit study: long-term imaging assessment. Neurology. 2003;60:A293.
  26. Schwingenschuh Petra, Ruge Diane, Edwards Mark J., Terranova Carmen, Katschnig Petra, Carrillo Fatima, Silveira-Moriyama Laura, Schneider Susanne A, Kägi Georg, Palomar Francisco J, Talelli Penelope, Dickson John, Lees Andrew J., Quinn Niall, Mir Pablo, Rothwell John C., Bhatia Kailash P., Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: A clinical and electrophysiological study, 10.1002/mds.23019